Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

G. Rosati, G. Aprile, Mario Scartozzi, F. Pasini, M. Cantore, D. Ferrari, S. Barni, R. Labianca, TOSCA (Three or Six Colon Adjuvant) Investigators, Guglielmo Nasti, Rosario Vincenzo Iaffaioli

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)2074-2081
Number of pages8
JournalAnnals of Oncology
Issue number11
Publication statusPublished - Nov 1 2016


  • Journal Article

Cite this